Publications by authors named "Marc A Schneider"

Claim this Profile
P
Plasma proteomic profiling and molecular clustering reveal immune-defined prognostic subtypes in lung adenocarcinoma.
Ujjwal Neogi, Anoop T Ambikan, Kati Turkowski, Marc A Schneider, Vanessa M Beutgen

Int J Cancer· February 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The transcriptome of CD14CD163HLA-DR monocytes predicts mortality in Idiopathic Pulmonary Fibrosis.
Theodoros Karampitsakos, Minxue Jia, Bochra Tourki, Zainab Fatima, Bogdan Visinescu, Marc A Schneider

Eur Respir J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a novel RSPO1-NUMT insertion in a LUAD patient cohort and the challenges and insights into NUMT detection highlighting the importance of reference genomes and population databases.
Ilona Tietzova, Dana Sochorova, Petr Triska, Rebecca C Rancourt, Marek Omelka, Marc A Schneider

Transl Lung Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Living human lung slices for ex vivo modelling of lung cancer.
Siavash Mansouri, Annika Karger, Clemens Ruppert, Marc A Schneider, Andreas Weigert

JCI Insight· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of lepidic growth in intermediate and high-grade lung adenocarcinoma.
Benedikt Niedermaier, Erik Rolf, Michael Allgäuer, Laura V Klotz, Marc A Schneider

Lung Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: results of the NEOMUN trial.
Martin E Eichhorn, Benedikt Niedermaier, Pornpimol Charoentong, Laura V Klotz, Philip Baum, Marc A Schneider

J Immunother Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis.
Ann-Kathrin Daum, Lisa Schlicker, Marc A Schneider, Thomas Muley, Ursula Klingmüller

Cancer Metab· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum levels of C-terminal peptides of alpha-1 antitrypsin as potential biomarkers in non-small cell lung cancer.
Marc A Schneider, Friedemann R Boerner, Michael Kiehntopf, Thomas Muley, Sabina Janciauskiene

Transl Lung Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNF20 links the DNA damage response and metabolic rewiring in lung cancer through HIF1α.
Hao Liu, Yongqin Tang, Anshu Singh, Joaquim Vong, Julio Cordero, Marc A Schneider

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-coverage whole genome sequencing of cell-free DNA to predict and track immunotherapy response in advanced non-small cell lung cancer.
Florian Janke, Mateo Gasser, Arlou K Angeles, Anja L Riediger, Magdalena Görtz, Marc A Schneider

J Exp Clin Cancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epitranscriptomic rRNA fingerprinting reveals tissue-of-origin and tumor-specific signatures.
Ivan Milenkovic, Sonia Cruciani, Laia Llovera, Morghan C Lucas, Rebeca Medina, Marc A Schneider

Mol Cell· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumor Heterogeneity Predicts Prognosis in Lepidic Predominant Lung Adenocarcinoma.
Benedikt Niedermaier, Michael Allgäuer, Thomas Muley, Marc A Schneider, Martin E Eichhorn

Thorac Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissecting AI-based mutation prediction in lung adenocarcinoma: A comprehensive real-world study.
Gabriel Dernbach, Daniel Kazdal, Lukas Ruff, Maximilian Alber, Eva Romanovsky, Marc A Schneider

Eur J Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pregnancy-associated protein glycodelin as a potential sex-specific target for resistance to immunotherapy in non-small cell lung cancer.
Sarah Richtmann, Sebastian Marwitz, Thomas Muley, Hannu Koistinen, Petros Christopoulos, Marc A Schneider

Transl Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Polymorphisms Associated with Overall Survival in Lung Adenocarcinoma: Genome-Wide Analysis.
Francesca Minnai, Sara Noci, Martina Esposito, Marc A Schneider, Sonja Kobinger

Cancers (Basel)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single-sample workflow for joint metabolomic and proteomic analysis of clinical specimens.
Hagen M Gegner, Thomas Naake, Karim Aljakouch, Aurelien Dugourd, Georg Kliewer, Marc A Schneider

Clin Proteomics· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of tumor markers ProGRP, NSE and CYFRA 21-1 in patients with small cell lung cancer and chemotherapy-induced remission.
Thomas Muley, Felix J Herth, Claus Peter Heussel, Mark Kriegsmann, Michael Thomas, Marc A Schneider

Tumour Biol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Detection of Lung Cancer Using Small RNAs.
Tobias Sikosek, Rastislav Horos, Franziska Trudzinski, Julia Jehn, Maurice Frank, Marc A Schneider

J Thorac Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary results from the EMoLung clinical study showing early lung cancer detection by the LC score.
Karla Rubio, Jason M Müller, Aditi Mehta, Iris Watermann, Till Olchers, Marc A Schneider

Discov Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Thoracic radiotherapy plus Durvalumab in elderly and/or frail NSCLC stage III patients unfit for chemotherapy - employing optimized (hypofractionated) radiotherapy to foster durvalumab efficacy: study protocol of the TRADE-hypo trial.
Farastuk Bozorgmehr, Inn Chung, Petros Christopoulos, Johannes Krisam, Marc A Schneider

BMC Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated circulating tumour DNA and cytokine analysis for therapy monitoring of ALK-rearranged lung adenocarcinoma.
Arlou Kristina Angeles, Florian Janke, Ann-Kathrin Daum, Martin Reck, Marc A Schneider

Br J Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD.
Uwe Schwartz, Maria Llamazares Prada, Stephanie T Pohl, Mandy Richter, Raluca Tamas, Marc A Schneider

EMBO J· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung Adenocarcinoma Diagnosed at a Younger Age Is Associated with Advanced Stage, Female Sex, and Ever-Smoker Status, in Patients Treated with Lung Resection.
Tommaso A Dragani, Thomas Muley, Marc A Schneider, Sonja Kobinger, Martin Eichhorn

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is iron deficiency caused by mutations or dysfunction in pulmonary arterial hypertension patients?
Vivienne Theobald, Ekkehard Grünig, Nicola Benjamin, Hans-Jürgen Seyfarth, Michael Halank, Marc A Schneider

Pulm Circ· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients.
Florian Janke, Arlou Kristina Angeles, Anja Lisa Riediger, Simone Bauer, Martin Reck, Marc A Schneider

Clin Epigenetics· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis